Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 58,226 shares at $73.32 ($4.3M) on 2020-05-19, disclosed to the SEC on 2020-05-20.
Seasonal sale ($4.3M) by CFO & Executive Vice President — this insider has traded RARE in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.29 | 2,392 | $175K | 4.1% |
| 2 | $73.29 | 2,392 | $175K | 4.1% |
| 3 | $73.34 | 19,593 | $1.4M | 33.7% |
| 4 | $73.34 | 19,593 | $1.4M | 33.7% |
| 5 | $73.32 | 3,221 | $236K | 5.5% |
| 6 | $73.32 | 3,221 |
| $236K |
| 5.5% |
| 7 | $73.32 | 3,907 | $286K | 6.7% |
| 8 | $73.32 | 3,907 | $286K | 6.7% |
| Total | $73.33 avg | 58,226 | $4.3M | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2019-04-17 | $133K | — | Filing → |